Plasma lipidome and risk of atrial fibrillation: results from the PREDIMED trial

[1]  L. Lind,et al.  Multicohort Metabolomics Analysis Discloses 9‐Decenoylcarnitine to Be Associated With Incident Atrial Fibrillation , 2021, Journal of the American Heart Association.

[2]  L. Liang,et al.  Lipid Profiles and Heart Failure Risk: Results from Two Prospective Studies. , 2020, Circulation research.

[3]  G. Hillis,et al.  Novel Lipid Species for Detecting and Predicting Atrial Fibrillation in Patients with Type 2 Diabetes. , 2020, Diabetes.

[4]  J. Lozano-Sánchez,et al.  Structure–Biological Activity Relationships of Extra-Virgin Olive Oil Phenolic Compounds: Health Properties and Bioavailability , 2020, Antioxidants.

[5]  D. Mozaffarian,et al.  Plasma Ceramides and Sphingomyelins in Relation to Atrial Fibrillation Risk: The Cardiovascular Health Study , 2020, Journal of the American Heart Association.

[6]  G. Tse,et al.  Blood lipid profiles and risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies. , 2019, Journal of clinical lipidology.

[7]  Yan V. Sun,et al.  Serum Metabolomics and Incidence of Atrial Fibrillation (from the Atherosclerosis Risk in Communities Study). , 2019, The American journal of cardiology.

[8]  Hugh Calkins,et al.  2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2019, Heart rhythm.

[9]  L. Liang,et al.  Lipid metabolic networks, Mediterranean diet and cardiovascular disease in the PREDIMED trial. , 2018, International journal of epidemiology.

[10]  L. Liang,et al.  Plasma Lipidomic Profiling and Risk of Type 2 Diabetes in the PREDIMED Trial , 2018, Diabetes Care.

[11]  P. Sanders,et al.  The Impact of Diet and Lifestyle on Atrial Fibrillation , 2018, Current Cardiology Reports.

[12]  M. Hernán,et al.  Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra‐Virgin Olive Oil or Nuts , 2018, The New England journal of medicine.

[13]  S. Kang,et al.  Lipidomic profiling reveals free fatty acid alterations in plasma from patients with atrial fibrillation , 2018, PloS one.

[14]  L. Liang,et al.  Plasma lipidome patterns associated with cardiovascular risk in the PREDIMED trial: A case-cohort study. , 2018, International journal of cardiology.

[15]  L. Liang,et al.  Plasma lipidomic profiles and cardiovascular events in a randomized intervention trial with the Mediterranean diet. , 2017, The American journal of clinical nutrition.

[16]  I. Lodhi,et al.  Structural and functional roles of ether lipids , 2017, Protein & Cell.

[17]  O. Fiehn,et al.  Potential Impact and Study Considerations of Metabolomics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association. , 2017, Circulation. Cardiovascular genetics.

[18]  M. Rienstra,et al.  Metabolomic Profiling in Relation to New-Onset Atrial Fibrillation (from the Framingham Heart Study). , 2016, The American journal of cardiology.

[19]  M. Waxham,et al.  Remodeling of the postsynaptic plasma membrane during neural development , 2016, Molecular biology of the cell.

[20]  Q. Tang,et al.  Peroxisome Proliferator-Activated Receptor-γ Is Critical to Cardiac Fibrosis , 2016, PPAR research.

[21]  R. Lamuela-Raventós,et al.  Extravirgin Olive Oil Consumption Reduces Risk of Atrial Fibrillation: The PREDIMED (Prevención con Dieta Mediterránea) Trial , 2014, Circulation.

[22]  A. Moser,et al.  Functions of plasmalogen lipids in health and disease. , 2012, Biochimica et biophysica acta.

[23]  Peter Bühlmann,et al.  Causal Inference Using Graphical Models with the R Package pcalg , 2012 .

[24]  Dolores Corella,et al.  Cohort profile: design and methods of the PREDIMED study. , 2012, International journal of epidemiology.

[25]  G. Schmitz,et al.  Plasmalogens the neglected regulatory and scavenging lipid species. , 2011, Chemistry and physics of lipids.

[26]  Dolores Corella,et al.  A short screener is valid for assessing Mediterranean diet adherence among older Spanish men and women. , 2011, The Journal of nutrition.

[27]  D. Kendall,et al.  Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease. , 2010, Immunobiology.

[28]  Peter Bühlmann,et al.  Predicting causal effects in large-scale systems from observational data , 2010, Nature Methods.

[29]  L. Pike.  Lipid rafts Published, JLR Papers in Press, February 1, 2003. DOI 10.1194/jlr.R200021-JLR200 , 2003, Journal of Lipid Research.

[30]  R. Zoeller,et al.  Deficiency in ethanolamine plasmalogen leads to altered cholesterol transport Published, JLR Papers in Press, November 4, 2002. DOI 10.1194/jlr.M200363-JLR200 , 2003, Journal of Lipid Research.

[31]  Y. Benjamini,et al.  THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY , 2001 .

[32]  J. C. Hinshaw,et al.  Oxidized Alkyl Phospholipids Are Specific, High Affinity Peroxisome Proliferator-activated Receptor γ Ligands and Agonists* , 2001, The Journal of Biological Chemistry.

[33]  N. Nagan,et al.  Plasmalogens: biosynthesis and functions. , 2001, Progress in lipid research.

[34]  P A Wolf,et al.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. , 1998, The American journal of cardiology.

[35]  R. Elosua,et al.  Validation of the Minnesota Leisure Time Physical Activity Questionnaire in Spanish men. The MARATHOM Investigators. , 1994, American journal of epidemiology.

[36]  R. L. Prentice,et al.  Retrospective studies and failure time models , 1978 .

[37]  F. David,et al.  Statistical Estimates and Transformed Beta-Variables. , 1960 .